BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12161679)

  • 1. Psychiatric prescribing trends and practices in Iowa's prisons.
    Lund BC; Flaum M; Adam LA; Perry PJ
    Psychiatr Serv; 2002 Aug; 53(8):1023-4. PubMed ID: 12161679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and appropriateness of psychotropic medication prescribing in a nationally representative cross-sectional survey of male and female prisoners in England.
    Hassan L; Senior J; Webb RT; Frisher M; Tully MP; While D; Shaw JJ
    BMC Psychiatry; 2016 Oct; 16(1):346. PubMed ID: 27724879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010.
    Ilyas S; Moncrieff J
    Br J Psychiatry; 2012 May; 200(5):393-8. PubMed ID: 22442100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and costs of antipsychotic agents: a Canadian population-based study, 1996-2006.
    Alessi-Severini S; Biscontri RG; Collins DM; Kozyrskyj A; Sareen J; Enns MW
    Psychiatr Serv; 2008 May; 59(5):547-53. PubMed ID: 18451015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial dental needs and a projection of needed dental capacity in the Iowa Department of Corrections.
    Ringgenberg WJ
    J Correct Health Care; 2011 Apr; 17(2):150-9. PubMed ID: 21525118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staff and patient perspectives on the purpose of psychotropic prescribing in prisons: care or control?
    Hassan L; Edge D; Senior J; Shaw J
    Gen Hosp Psychiatry; 2013; 35(4):433-8. PubMed ID: 23433823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate care programs for inmates with psychiatric disorders.
    Condelli WS; Dvoskin JA; Holanchock H
    Bull Am Acad Psychiatry Law; 1994; 22(1):63-70. PubMed ID: 8193390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the reasons for prescribing and misuse of gabapentinoids in prison including their co-prescription with opioids and antidepressants.
    Soni A; Walters P
    Int J Prison Health; 2019 Aug; 16(1):67-77. PubMed ID: 32040271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark.
    Steinhausen HC; Bisgaard C
    Acta Psychiatr Scand; 2014 Mar; 129(3):221-31. PubMed ID: 23738593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Appropriateness of Antipsychotic Prescribing in an Italian Prison: Is Everything Always Really Overprescribed?
    Pelizza L; Maestri D; Paulillo G; Pellegrini P
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):31-36. PubMed ID: 34928558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Austrian expenditures on psychopharmaceutical drugs between 2006 and 2013].
    Boeckle M; Chetouani Y; Schrimpf M; Liegl G; Leitner A; Pieh C
    Z Psychosom Med Psychother; 2015; 61(4):359-69. PubMed ID: 26646914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a clinical and evidence-based strategy to preserve access to psychiatric medications.
    Duckworth K; Hanson A
    Psychiatr Serv; 2002 Oct; 53(10):1231-2. PubMed ID: 12364666
    [No Abstract]   [Full Text] [Related]  

  • 13. Can morbidity be inferred from prescription drug use? Results from a nation-wide prison population study.
    Kjelsberg E; Hartvig P
    Eur J Epidemiol; 2005; 20(7):587-92. PubMed ID: 16119431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental Illness and Prisoners: Concerns for Communities and Healthcare Providers.
    Hoke S
    Online J Issues Nurs; 2015 Jan; 20(1):3. PubMed ID: 26824261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are psychiatric disorders identified and treated by in-prison health services?].
    Langeveld H; Melhus H
    Tidsskr Nor Laegeforen; 2004 Aug; 124(16):2094-7. PubMed ID: 15334122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central New York Psychiatric Center: an approach to the treatment of co-occurring disorders in the New York State correctional mental health system.
    Smith H; Sawyer DA; Way BB
    Behav Sci Law; 2002; 20(5):523-34. PubMed ID: 12239710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of mental disorder and related treatments in a local jail: a 20-month consecutive case study].
    CarrĂ  G; Giacobone C; Pozzi F; Alecci P; Barale F
    Epidemiol Psichiatr Soc; 2004; 13(1):47-54. PubMed ID: 15248393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental healthcare interfaces in a regional Irish prison.
    Gulati G; Otuokpaikhian K; Crowley M; Pradeep V; Meagher D; Dunne CP
    Int J Prison Health; 2019 Mar; 15(1):14-23. PubMed ID: 30827156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correctional treatment for co-occurring disorders: results of a national survey.
    Peters RH; LeVasseur ME; Chandler RK
    Behav Sci Law; 2004; 22(4):563-84. PubMed ID: 15282840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms and treatment of mental illness among prisoners: a study of Michigan state prisons.
    Fries BE; Schmorrow A; Lang SW; Margolis PM; Heany J; Brown GP; Barbaree HE; Hirdes JP
    Int J Law Psychiatry; 2013; 36(3-4):316-25. PubMed ID: 23688801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.